Abstract:Polymyxin resistance principally arises from structural remodeling of bacterial surface lipid A. Lipid A modifiers associated with intrinsic cationic antimicrobial polypeptide (CAMP) resistance include ArnT, EptA, and the AlmEFG system. Whereas ArnT and EptA are prevalent across species, the AlmEFG tripartite machinery is restricted to the EI Tor biotype of V. cholerae O1. The newly discovered and rapidly evolving MCR family of enzymes are functionally unified in their catalytic action and consequent ability to confer colistin resistance. Polymyxins are a group of detergent-like antimicrobial peptides that are the ultimate line of defense against carbapenem-resistant pathogens in clinical settings. Polymyxin resistance primarily originates from structural remodeling of lipid A anchored on bacterial surfaces. We integrate genetic, structural, and biochemical aspects of three major types of lipid A modifiers that have been shown to confer intrinsic colistin resistance. Namely, we highlight ArnT, a glycosyltransferase, EptA, a phosphoethanolamine transferase, and the AlmEFG tripartite system, which is restricted to EI Tor biotype of Vibrio cholerae O1. We also discuss the growing family of mobile colistin resistance (MCR) enzymes, each of which is analogous to EptA, and which pose great challenges to global public health. Polymyxins are a group of detergent-like antimicrobial peptides that are the ultimate line of defense against carbapenem-resistant pathogens in clinical settings. Polymyxin resistance primarily originates from structural remodeling of lipid A anchored on bacterial surfaces. We integrate genetic, structural, and biochemical aspects of three major types of lipid A modifiers that have been shown to confer intrinsic colistin resistance. Namely, we highlight ArnT, a glycosyltransferase, EptA, a phosphoethanolamine transferase, and the AlmEFG tripartite system, which is restricted to EI Tor biotype of Vibrio cholerae O1. We also discuss the growing family of mobile colistin resistance (MCR) enzymes, each of which is analogous to EptA, and which pose great challenges to global public health. polymyxins, which are naturally produced by Paenibacillus polymyxa, are paradigmatic CAMP members. In addition, an endogenous CAMP represents a most ancient (and/or efficient) defense system in the context of host innate immunity. refers to the lipid A moiety linked to LPS, an important surface component of Gram-negative bacterium. Lipid A is a bis-phosphorylated derivative of β-1,6-linked D-glucosamine disaccharide with various types of fatty acyl chains in amide linkages. a growing body of MCR enzymes, the prototype being MCR-1, that can be transferred by diverse plasmids across enteric flora. a two-component signal transduction system regulating phenotypic polymyxin resistance, of which PmrA is a response regulator. a collection of integral membrane enzymes within the alkaline phosphatase superfamily. In general, they consist of a transmembrane domain and a soluble catalytic domain. The former domain anchors the enzyme to the periplasmic face of the cytoplasmic membrane.

Pseudomonas aeruginosa MipA-MipB envelope proteins act as new sensors of polymyxins

Identification of Novel phoP-phoQ Regulated Genes that Contribute to Polymyxin B Tolerance in Pseudomonas aeruginosa

Bacterial outer membrane vesicles increase polymyxin resistance in Pseudomonas aeruginosa while inhibiting its quorum sensing

Polymyxins Bind to the Cell Surface of Unculturable Acinetobacter baumannii and Cause Unique Dependent Resistance

MvfR Controls Tolerance to Polymyxin B by Regulating rfaD in Pseudomonas aeruginosa

PmrAB, a Two-Component Regulatory System of Pseudomonas aeruginosa That Modulates Resistance to Cationic Antimicrobial Peptides and Addition of Aminoarabinose to Lipid A

Mechanistic and biophysical characterization of polymyxin resistance response regulator PmrA in Acinetobacter baumannii

Drug efflux and lipid A modification by 4-L-aminoarabinose are key mechanisms of polymyxin B resistance in the sepsis pathogen Enterobacter bugandensis

Two Regulators, PA3898 and PA2100, Modulate the Pseudomonas aeruginosa Multidrug Resistance MexAB-OprM and EmrAB Efflux Pumps and Biofilm Formation

Genetic and Biochemical Mechanisms for Bacterial Lipid A Modifiers Associated with Polymyxin Resistance

Polymyxin B1 in the Escherichia coli inner membrane: A complex story of protein and lipopolysaccharide-mediated insertion

IS1-mediated chromosomal amplification of the arn operon leads to polymyxin B resistance in Escherichia coli B strains

Biosensor-guided detection of outer membrane-specific antimicrobial activity against Pseudomonas aeruginosa from fungal cultures and medicinal plant extracts

Lipid A in outer membrane vesicles shields bacteria from polymyxins

Changes in the expression of mexB , mexY , and oprD in clinical Pseudomonas aeruginosa isolates

An Evolutionarily Conserved Mechanism for Intrinsic and Transferable Polymyxin Resistance.

A Putative ABC Transporter Permease Is Necessary for Resistance to Acidified Nitrite and EDTA in Pseudomonas aeruginosa under Aerobic and Anaerobic Planktonic and Biofilm Conditions

PBP Target Profiling by β-Lactam and β-Lactamase Inhibitors in Intact Pseudomonas aeruginosa: Effects of the Intrinsic and Acquired Resistance Determinants on the Periplasmic Drug Availability

A novel decoy strategy for polymyxin resistance in Acinetobacter baumannii

Outer Membranes of Polymyxin-Resistant Acinetobacter Baumannii with Phosphoethanolamine-Modified Lipid A and Lipopolysaccharide Loss Display Different Atomic-Scale Interactions with Polymyxins

The Pseudomonas aeruginosa efflux pump MexGHI-OpmD transports a natural phenazine that controls gene expression and biofilm development